FCH
VIVS

Freestone Capital Holdings’s VivoSim Labs VIVS Stock Holding History

Freestone Capital Holdings’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-50
Closed -$16K – 363
2017
Q4 		$16K Hold
50
– – ﹤0.01% 333
2017
Q3 		$27K Hold
50
– – ﹤0.01% 340
2017
Q2 		$32K Hold
50
– – ﹤0.01% 329
2017
Q1 		$38K Hold
50
– – ﹤0.01% 339
2016
Q4 		$41K Buy
+50
New +$39.7K ﹤0.01% 346

Other funds holding VIVS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Freestone Capital Holdings's VIVS Position: Q1 2018 in Review

Freestone Capital Holdings sold out of VivoSim Labs (VIVS) in Q1 2018, closing a stake of 50 shares — an estimated $16K sold.

Freestone Capital Holdings first reported a position in VIVS in Q4 2016 and held it in 5 quarters. The position peaked at $41K in Q4 2016. 105 funds tracked by Wall St. Rank hold VIVS as of Q1 2018.

  • Freestone Capital Holdings reported no remaining VivoSim Labs position as of Q1 2018 after selling out during the quarter.
  • Freestone Capital Holdings sold 50 VivoSim Labs shares in Q1 2018, an estimated $16K.
  • Freestone Capital Holdings first reported a position in VivoSim Labs in Q4 2016 and held it in 5 quarters.
  • Freestone Capital Holdings's VivoSim Labs position peaked at $41K in Q4 2016.
  • 105 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2018.

Based on Freestone Capital Holdings's 13F filing for Q1 2018, filed 15 May 2018.